4. Induced Hypotension, Clonidine + Dexdor Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Indications:

A

should be used only to make the impossible possible, and not the possible easy

largely oblivious to that injunction and requested hypotension for any
procedure that involved blood loss

one example of which is the removal of choroidal tumours of the eye.
Moderate hypotension (as defined by a reduction in mean arterial pressure [MAP]
by up to 30%) is used for various operations,

including endoscopic sinus surgery,
middle ear surgery and
maxillary and mandibular osteotomies.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Intravenous Drugs That Can Be Used to Induce Hypotension

Ideal agent

A

would include pharmacological stability and ease of preparation and administration
very rapid onset and offset of action,

with no rebound hypertension;
rapid metabolism and excretion,
with no direct or indirect organ toxicity;

a linear and predictable dose-response relationship

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

The prime determinants of arterial blood pressure (BP)

A

The prime determinants of arterial blood pressure (BP) are cardiac output (CO),
which is the product of heart rate (HR) and stroke volume (SV), and systemic
vascular resistance (SVR). Drugs used to induce hypotension can affect one or more
of these variables.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Drugs Which Affect Systemic Vascular Resistance (SVR)

A

α-Adrenoceptor Blockers
Phentolamine: this is a non-selective α antagonist (the ratio of α1:α2 effects is 3:1),
which also has weak β-sympathomimetic action. It decreases BP by reducing
peripheral resistance owing to its peripheral α1-vasoconstrictor blockade and mild
β-sympathomimetic vasodilatation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Peripheral Vasodilators

GTN

A

Glyceryl trinitrate (GTN) nitroglycerine:

its hypotensive action is mediated via nitric oxide (NO).

NO activates guanylate cyclase,
which increases cyclic GMP
(from guanosine triphosphate) within cells.

This in turn decreases available intracellular Ca2+.

The drug causes more venous than arteriolar dilatation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Sodium nitroprusside (SNP)

A

Sodium nitroprusside (SNP): SNP is another nitrovasodilator which mediates hypotension
via NO. In contrast to GTN, it causes both arterial and venous dilatation,
leading to hypotension and a compensatory reflex tachycardia

complex metabolism that results in the production of free cyanide (CN−), which, by
binding irreversibly to cytochrome oxidase in mitochondria, is highly toxic, causing
tissue hypoxia and acidosis

Treatment of toxicity is with sodium thiosulphate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Ganglion Blockers

A

Ganglion Blockers
Trimetaphan (trimethaphan): this agent is no longer available in the UK, but it was
a popular hypotensive drug, particularly in neurosurgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Direct Vasodilators

A

Hydralazine: this produces hypotension by direct vasodilatation together with a
weak α-antagonist action. This is mediated via an increase in cyclic GMP and
decrease in available intracellular Ca2+.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drugs Which Affect Cardiac Output (CO)

A

β-adrenoceptor blockers: there are many examples – all are competitive antagonists,
but their selectivity for receptors is variable. Selective β1-antagonism is clearly a
useful characteristic. Their influence on BP is probably because of decreased CO via a
decreased HR,

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Atenolol

A

Atenolol: this is a selective β1-antagonist except in high doses. It is long acting, with a
t½ of around 7 hours. Its use as a bolus (150 μg kg−1 over 20 minutes) is usually to
treat cardiac arrhythmias rather than to induce hypotension.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Esmolol

A

: this is a relatively selective β1-antagonist. It is ultra-short acting, with a t½
of around 9 minutes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Labetalol

A

Labetalol: this acts both as α- and β-antagonist

which mediates a decrease in SVR without reflex tachycardia. It is a
popular drug in anaesthetic, obstetric anaesthetic and intensive therapy use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Propanolol

A

Propanolol: this is a non-selective β-antagonist which is usually given as a bolus of
1.0 mg, repeated to a maximum of 5.0 mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

α2-Adrenoceptor Agonists

A

Clonidine: this is an α-agonist with affinity for α2-receptors some 200 times greater
than that for α1. Its hypotensive effects are mediated via a reduction in central sympathetic outflow and by stimulation of presynaptic α2-receptors which inhibit
noradrenaline release into the synaptic cleft.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Complications and Risks of Induced Hypotension

A

Dangers and complications: these relate predictably to the consequences of
hypoperfusion in key parts of the circulation. Precipitate falls in BP may lead to
cerebrovascular hypoperfusion and stroke, and to myocardial ischaemia

Druginduced
hypotension usually shifts the autoregulatory curve to the left, and thereby
confers a degree of protection

patients who are previously hypertensive, however,
the curve is shifted to the right, making them more vulnerable to catastrophic drops
in perfusion of essential areas

As a generalization, however, the accepted recommendation is to
keep the MAP above 50 mmHg in the young and above 80 mm in elderly subjects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exacerbating influences:

A

the effects of induced hypotension will be enhanced by
factors such as hypovolaemia, the use of other drugs with hypotensive actions such as
volatile anaesthetic agents, the reduction in venous return associated with IPPV and
drugs which release histamine. The head-up position may also further diminish
effective cerebral perfusion.

17
Q

Clonidine

A

Clonidine is an agonist at α2-adrenoceptors (the ratio of α1:α2 is 1:200)

imidazole receptors
located centrally and appear to mediate sedation and hypnosis

18
Q

Acts @

A

acts at presynaptic α2-receptors, both centrally and peripherally,
to inhibit the release of noradrenaline.

In the hypothalamus, α2-receptors are inhibitory to the vasomotor outflow.

Clonidine also acts post-synaptically in the adrenal medulla.

α2-agonists activate receptors in the substantia gelatinosa
in the dorsal horn of the spinal cord,

which inhibits transmission down nociceptive neurons
stimulated by Aδ and C fibres.

They also inhibit the release of the nociceptive neurotransmitter Substance P.

19
Q

Pharmacokinetics

A

: the oral bioavailability of clonidine is 70–80%, with peak levels
attained at between 1 and 3 hours.

Following intravenous administration, the distribution half-life is around 20 minutes and the elimination half-life quoted as between 12 and 16 hours.

It undergoes hepatic metabolism, although 20–40% of an
oral dose is excreted unchanged

20
Q

The anaesthetic and medical uses of clonidine are numerous

A
  1. Stress and pressor responses
  2. Adjunctive use in anaesthesia and analgesia:
    dose of 1–2 μg kg−1 intravenously
    reduces the MAC of inhaled volatile agents and decreases the requirement for
    systemic analgesics.
  3. Hypotensive anaesthesia:
    1–2 μg kg− 1 intravenously can produce modest and
    sustained hypotension which may improve operating conditions during which
    bleeding would otherwise mask the surgical field
  4. Antisialogogue effect:
    a side effect of clonidine administration is reduced salivary
    secretion; this property can be useful in the perioperative period.
  5. Alcohol withdrawal:
    clonidine inhibits the exaggerated release of sympathomimetic
    neurotransmitters during acute alcohol withdrawal.
  6. Sedation and anxiolyis:
    it has both sedative and anxiolytic actions.
    It finds use as pre-operative medication
    (up to 4 μg kg−1 in both adults and children
    although the
    onset of action is relatively slow
  7. Neuropathic pain:
    clonidine can attenuate symptoms in some patients. It is particularly
    effective when given through an intrathecal drug delivery system.
    Shivering: a low dose (up to 0.5 μg kg−1) may ameliorate postanaesthetic shivering.
  8. Adjuvant use in regional anaesthesia
21
Q

Dexmedetomidine

A

: this is the R isomer of medetomidine,
which has the advantage
of being a more selective α2-agonist than clonidine

with reported ratios of α2:α1
activity of 220:1 for clonidine and 1620:1 for dexmedetomidine);

Their highest densities are found in the
locus coeruleus which, amongst other functions, mediates alertness. It also contains a
descending noradrenergic pathway which modulates nociceptive transmission

effective anxiolytic, sedative and analgesic than clonidine. It otherwise has the same
overall spectrum of activity, and the dose ranges are similar

22
Q

Pharmacokinetics

A

Pharmacokinetics:

following intravenous administration,

dexmedetomidine has a rapid distribution half-life of 6 minutes
a terminal elimination half-life of around 2 hours.

Its steady state volume of distribution is 118 L.

It is highly protein-bound (94%),
mainly to albumin, and undergoes hepatic metabolism via cytochrome P450
and by the formation of glucuronides.

Elimination is predominantly renal (95%), with the remainder being excreted in faeces